SmithKline Beecham (SKB) to market Osteomark:
This article was originally published in Clinica
SmithKline Beecham Clinical Laboratories will market Ostex' bone resorption assay, Osteomark, in the US through its reference laboratory testing services. The agreement with SmithKline Beecham complements the existing arrangement with Corning (MetPath), says Ostex' chairman and CEO, Ray Cairncross. Ostex also has a marketing co-operation agreement with Merck & Co.